About this Journal Submit a Manuscript Table of Contents
Journal of Chemistry
Volume 2013 (2013), Article ID 656271, 6 pages
http://dx.doi.org/10.1155/2013/656271
Research Article

Synthesis and Evaluation of Some New Thiazolidin-4-One Derivatives as Potential Antimicrobial Agents

1Department of Pharmaceutical Chemistry, Government College of Pharmacy, Kathora Naka, Amravati, Maharashtra 444 604, India
2Department of Pharmacognosy & Phytochemistry, Government College of Pharmacy, Kathora Naka, Amravati, Maharashtra 444 604, India
3Department of Pharmacognosy & Phytochemistry, Government College of Pharmacy, Hotel Vedant Road, Osmanpura, Aurangabad, Maharashtra 431 005, India

Received 25 June 2012; Accepted 17 August 2012

Academic Editor: Hakan Arslan

Copyright © 2013 B. A. Baviskar et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. A. Andreani, M. Granaiola, A. Leoni, A. Locatelli, R. Morigi, and M. Rambaldi, “Synthesis and antitubercular activity of imidazo[2,1-b]thiazoles,” European Journal of Medicinal Chemistry, vol. 36, no. 9, pp. 743–746, 2001. View at Publisher · View at Google Scholar · View at Scopus
  2. J. Clough, S. Chen, E. M. Gordon et al., “Combinatorial modification of natural products: synthesis and in vitro analysis of derivatives of thiazole peptide antibiotic GE2270 A: a-ring modifications,” Bioorganic and Medicinal Chemistry Letters, vol. 13, no. 20, pp. 3409–3414, 2003. View at Publisher · View at Google Scholar · View at Scopus
  3. S.N. Pandeya, D. Sriram, G. Nath, and E. Declercq, “Synthesis, antibacterial, antifungal and anti-HIV activities of Schiff and Mannich bases derived from isatin derivatives and N-[4-(4'-chlorophenyl)thiazol-2-yl] thiosemicarbazide,” European Journal of Pharmaceutical Sciences, vol. 9, no. 1, pp. 25–31, 1999. View at Publisher · View at Google Scholar
  4. B. Baviskar, S. Patel, B. A. Baviskar, S. S. Khadabadi, and M. R. Shiradkar, “Design and synthesis of some novel chalcones as potent antimicrobial agent,” Asian Journal of Research in Chemistry, vol. 1, no. 2, pp. 67–69, 2008.
  5. A. H. M. Raemakers, F. T. N. Alleuigin, J. Vandenherk, P. J. A. Domoen, T. T. T. Ottenwert, and P. A. J. Janssen, “Novel broad-spectrum anthelmintics. Tetramisole and related derivatives of 6-arylimidazo[2,1-b]thiazole,” Journal of Medicinal Chemistry, vol. 54, no. 4, pp. 545–551, 1966. View at Publisher · View at Google Scholar
  6. S. K. Sharma, M. Tandeon, and J. W. Lown, “Design and synthesis of novel thiazole-containing cross-linked polyamides related to the antiviral antibiotic distamycin,” Journal of Organic Chemistry, vol. 65, no. 4, pp. 1102–1107, 2000. View at Publisher · View at Google Scholar
  7. P. K. Sharma, S. N. Sawhney, A. Gupta, G. B. Singh, and S. Bani, “Synthesis and antiinflammatory activity of some 3-(2-thiazolyl)-1,2-benzisothiazoles,” Indian Journal of Chemistry B, vol. 37, p. 376, 1998.
  8. M. R. Shiradkar, K. K. Murahari, H. R. Gangadasu et al., “Synthesis of new S-derivatives of clubbed triazolyl thiazole as anti-Mycobacterium tuberculosis agents,” Bioorganic and Medicinal Chemistry, vol. 15, no. 12, pp. 3997–4008, 2007. View at Publisher · View at Google Scholar · View at Scopus
  9. E. M. Hodnett and W. J. Dunn, “Structure-antitumor activity correlation of some Schiff bases,” Journal of Medicinal Chemistry, vol. 13, no. 4, pp. 768–770, 1970. View at Publisher · View at Google Scholar
  10. S. Narayanaswami and K. Richardson, European Patent, 1983, 96, 569 A1.
  11. M. B. Gravestock and M. Barry, European Patent, 1984, EP 94, 146B1.
  12. B. Hirsch, D. Lohmann, G. Menzel, G. Schuster, and E. Stenz, German Democratic Republic Patent, 1983, DD2, 34, 003.
  13. T. Ikeda and K. Tada, European Patent, 1988, EP 2,62,589 B1.
  14. B. D. Naik and K. R. Desai, “Synthesis of some heterocyclic Schiff base and azetidinone compounds and their antibacterial activity,” Asian Journal of Chemistry, vol. 16, no. 3-4, pp. 1749–1752, 2004. View at Scopus
  15. D. U. Warad, C. D. Satish, V. H. Kulkarni, and C. S. Bajgur, “Synthesis, structure and reactivity of zircordum(IV), vanadium(IV), cobalt(II), nickel(II) and copper(II) complexes derived from carbohydrazide schiff base ligands,” Indian Journal of Chemistry A, vol. 39, no. 4, pp. 415–420, 2000. View at Scopus
  16. S. Desai, P. B. Desai, and K. R. Desai, “Synthesis of new heterocyclic thiazolidinone and azetidinone compounds and their anticancer activity,” Heterocyclic Communications, vol. 5, no. 4, pp. 385–387, 1999. View at Scopus
  17. R. B. Lesyk and B. S. Zimenkovsky, “4-Thiazolidones: centenarian history, current status and perspectives for modern organic and medicinal chemistry,” Current Organic Chemistry, vol. 8, no. 16, pp. 1547–1577, 2004. View at Publisher · View at Google Scholar · View at Scopus
  18. M. V. Diurno, O. Mazzoni, F. Capasso, A. A. Izzo, and A. Bolognese, “Synthesis and pharmacological activity of 2-(substituted phenyl)-3{2 or 3-[(4-substituted phenyl-4-hydroxy)piperidino]ethyl or propyl}-1,3- thiazolidin-4-ones,” Farmaco, vol. 52, no. 4, pp. 237–241, 1997. View at Scopus
  19. N. Ergenc and G. Capan, “Synthesis and anticonvulsant activity of new 4-thiazolidone and 4- thiazoline derivatives,” Farmaco, vol. 49, no. 6, pp. 449–451, 1994. View at Scopus
  20. S. Desai, R. Desai, and N. Chandra Desai, “Vitamin A intervention in the Thar Desert,” Indian Journal of Ophthalmology, vol. 51, no. 4, pp. 361–363, 2003. View at Scopus
  21. R. C. Sharma and D. Kumar, “Synthesis of some new thiazolidin-4-ones as possible antimicrobial agents,” Journal of Indian Chemical Society, vol. 77, no. 10, pp. 492–493, 2000.
  22. E. Piscapo, M. V. Diurno, R. Gagliardi, and O. Mazzoni, “Studies on heterocyclic compounds: 1,3-thiazolidin-4-one derivatives. IV. Biological activity of variously substituted 2,3-diaryl-1,3-thiazolidin-4-ones,” Bollettino Della Societa Italiana di Biologia Sperimentale, vol. 65, no. 9, pp. 853–859, 1989.
  23. H. Ueno, T. Oe, I. Snehiro, and S. Nakamura, “US Patent, 5594116, 1997,” Chemical Abstracts, vol. 126, 157507 pages, 1977.
  24. T. Previtera, M. G. Vigorita, M. Bisila, F. Orsini, F. Benetolla, and G. Bombieri, “3,3'-Di [1,3-thiazolidine-4-one] system. VI. Structural and conformational studies on configurational isomers with antihistaminic activity,” European Journal of Medicinal Chemistry, vol. 29, no. 4, pp. 317–324, 1994. View at Publisher · View at Google Scholar
  25. M. V. Diurno, O. Mazzoni, G. Correale et al., “Synthesis and structure-activity relationships of 2-(substituted phenyl)-3-[3-(N,N-dimethylamino)propyl]-1,3-thiazolidin-4-ones acting as H1-histamine antagonists,” Farmaco, vol. 54, no. 9, pp. 579–583, 1999. View at Publisher · View at Google Scholar · View at Scopus
  26. M. Y. Ebeid, O. A. Fathallah, M. I. El-Zaher, M. M. Kamel, W. A. Abdon, and M. M. Anwar, “New tetralyl thiazoles the anti- HIV and anticancer screening of 3-4-[6(1,2,3,4-tetrahydronaphthyl)-thiazol-2-yl-2-(p-chlorophenyl)-thiazolidin-4-one,” Bulletin of Faculty of Pharmacy, vol. 34, p. 125, 1996.
  27. R. K. Rawal, Y. S. Prabhakar, S. B. Katti, and E. De Clercq, “2-(Aryl)-3-furan-2-ylmethyl-thiazolidin-4-ones as selective HIV-RT Inhibitors,” Bioorganic and Medicinal Chemistry, vol. 13, no. 24, pp. 6771–6776, 2005. View at Publisher · View at Google Scholar · View at Scopus
  28. R. Ottaná, E. Mazzon, L. Dugo et al., “Modeling and biological evaluation of 3,3′-(1,2-ethanediyl)bis[2-(4-methoxyphenyl)-thiazolidin-4-one], a new synthetic cyclooxygenase-2 inhibitor,” European Journal of Pharmacology, vol. 448, no. 1, pp. 71–80, 2002. View at Publisher · View at Google Scholar · View at Scopus
  29. H. Koike, N. Imanashi, Y. Natsume, and S. Morooka, “Effects of platelet activating factor receptor antagonists on intracellular platelet activating factor function in neutrophils,” European Journal of Pharmacology, vol. 269, no. 3, pp. 299–309, 1994. View at Publisher · View at Google Scholar
  30. Y. Tanabe, H. Yamamoto, M. Murakami et al., “Synthetic study of the highly potent and selective anti-platelet activating factor thiazolidin-4-one agents and related compounds,” Journal of the Chemical Society, no. 7, pp. 935–947, 1995. View at Scopus
  31. Y. Tanabe, G. Suzukamo, Y. Komuro et al., “Structure-activity relationship of optically active 2-(3-pyridyl)thiazolidin-4-ones as a PAF antagonist,” Tetrahedron Letters, vol. 32, no. 3, pp. 379–382, 1991. View at Publisher · View at Google Scholar · View at Scopus
  32. M. R. Shiradkar, P. Unnat, A. K. Chakravarthy, A. Maheta, and V. S. K. Gorentla, “Microwave assisted synthesis and antimicrobial screening of fused triazoles,” ARKIVOC, vol. 14, pp. 141–154, 2006.
  33. R. M. Dodson and L. C. King, “The reaction of ketones with halogens and thiourea,” Journal of the American Chemical Society, vol. 67, p. 2242, 1945.
  34. B. A. Baviskar, M. R. Shiradkar, S. S. Khadabadi, S. L. Deore, and K. G. Bothara, “Synthesis of thiazolyltriazole subtituted azetidiones as antinacrobial agents,” Indian Journal of Chemistry B, vol. 50B, pp. 321–325, 2011.
  35. M. Shiradkar, R. Kale, B. Baviskar, and R. Dighe, “Microwave assisted synthesis and antimicrobial screening of pyrazoline-5-ones,” Asian Journal of Chemistry, vol. 19, no. 1, pp. 449–453, 2007. View at Scopus
  36. B. A. Baviskar, B. Baviskar, S. Chuadhary et al., “Synthesis of novel benzimidazole derivatives as potent antimicrobial agent,” RASAYAN Journal of Chemistry, vol. 2, no. 1, pp. 186–190, 2009.
  37. Indian Pharmacopoeia, Ministry of Health and Family Welfare, New Delhi, 1996, A-114.
  38. B. A. Baviskar, B. Baviskar, M. R. Shiradkarm, U. A. Deokate, and S. S. Khadabadi, “Synthesis and antimicrobial activity of some novel benzimidazolyl chalcones,” E-Journal of Chemistry, vol. 6, no. 1, pp. 196–200, 2009. View at Scopus